At a glance
- Originator SSP Co
- Class Antifungals; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 28 Nov 2003 No development reported - Phase-II for Mycoses in United Kingdom (IV)
- 09 Feb 2001 Phase-II clinical trials for Mycoses in United Kingdom (IV)
- 06 Apr 2000 Yoshitomi is now called Welfide Corporation